Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1922]
News [4581]
Articles [462]
Editorials [10]
Conferences [114]
elearning [42]

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano
SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )
13 Dec 2023

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours ( Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India )
7 Dec 2023

Special issue on real world breast cancer data

Dr Siddhartha Kar - University of Cambridge, Cambridge, UK
Special issue on real world breast cancer data ( Dr Siddhartha Kar - University of Cambridge, Cambridge, UK )
21 Nov 2023

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer

Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany
Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer ( Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany )
21 Nov 2023

ESMO 2023: Highlights and analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2023: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Nov 2023

Breast Cancer

Dr Nita Nair - Apollo Cancer Centres, Mumbai
Breast Cancer ( Dr Nita Nair - Apollo Cancer Centres, Mumbai )
6 Nov 2023

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )
27 Oct 2023

Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer

Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )
23 Oct 2023

Effects of short-term fasting on quality of life as an add-on option during chemotherapy

Dr Daniela Koppold-Liebscher - Charité Universitätsmedizin Berlin, Berlin, Germany
Effects of short-term fasting on quality of life as an add-on option during chemotherapy ( Dr Daniela Koppold-Liebscher - Charité Universitätsmedizin Berlin, Berlin, Germany )
22 Oct 2023

Genomic testing: Awareness and effective communication between healthcare professionals and patients

Prof Richard Simcock and Antonella Cardone
Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )
22 Oct 2023

Myeloma treatment and prognosis

Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine, Kolkata, India
Myeloma treatment and prognosis ( Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine, Kolkata, India )
10 Oct 2023

Interpreting the results of a clinical trial

Dr Sanjit Agrawal, Tata Medical Center, Kolkata,India
Interpreting the results of a clinical trial ( Dr Sanjit Agrawal, Tata Medical Center, Kolkata,India )
10 Oct 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation